Live Breaking News & Updates on China universal asset management co

Stay informed with the latest breaking news from China universal asset management co on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in China universal asset management co and stay connected to the pulse of your community

AstraZeneca (NASDAQ:AZN) PT Raised to $82.00

AstraZeneca (NASDAQ:AZN) PT Raised to $82.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

China , Nasdaq , China-universal-asset-management-co , Jefferies-financial-group , Astrazeneca , Commonwealth-equity-services , Pinnacle-associates-ltd , Monte-financial-group , Astrazeneca-company-profile , Deutsche-bank-aktiengesellschaft , Morgan-stanley

Blueprint Medicines' (BPMC) Buy Rating Reaffirmed at Needham & Company LLC

Blueprint Medicines' (BPMC) Buy Rating Reaffirmed at Needham & Company LLC
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , China , Michael-landsittel , Stifel-nicolaus , Jeffreyw-albers , Blueprint-medicines-corporation , Needham-company , China-universal-asset-management-co , Cutler-group , Citigroup , Compass-wealth-management , Financial-services-group-inc

Phathom Pharmaceuticals' (PHAT) "Buy" Rating Reiterated at Needham & Company LLC

Needham & Company LLC reiterated their buy rating on shares of Phathom Pharmaceuticals (NASDAQ:PHAT – Free Report) in a research note released on Friday, Benzinga reports. They currently have a $26.00 price target on the stock. Phathom Pharmaceuticals Stock Up 1.9 % PHAT stock opened at $9.35 on Friday. The stock has a market capitalization […]

Wellington , New-zealand-general- , New-zealand , China , United-states , Canada , Molly-henderson , Terrie-curran , China-universal-asset-management-co , Barclays-plc , Institutional-trading-of-phathom-pharmaceuticals , Insider-activity-at-phathom-pharmaceuticals

abrdn plc Purchases New Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)

abrdn plc acquired a new position in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 72,032 shares of the company’s stock, valued at approximately $1,459,000. abrdn plc owned approximately 0.22% of Tarsus Pharmaceuticals as of […]

China , United-states , Bobakr-azamian , Aziz-mottiwala , Zurcher-kantonalbank-zurich-cantonalbank , Tarsus-pharmaceuticals-inc , Tarsus-pharmaceuticals-company-profile , Securities-exchange-commission , Mirae-asset-global-investments-co , Tarsus-pharmaceuticals-stock , Quarter-for-tarsus-pharmaceuticals , News-ratings-for-tarsus-pharmaceuticals-daily

abrdn plc Makes New Investment in Caribou Biosciences, Inc. (NASDAQ:CRBU)

abrdn plc purchased a new stake in shares of Caribou Biosciences, Inc. (NASDAQ:CRBU – Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor purchased 181,487 shares of the company’s stock, valued at approximately $1,040,000. Several other institutional investors have also added to or reduced their stakes […]

United-states , Florida , China , Board-of-administration-florida-retirement-system , Nasdaq , Mutual-advisors , China-universal-asset-management-co , Principal-financial-group-inc , Caribou-biosciences-company-profile , Caribou-biosciences-inc , E-fund-management-co

Zillow Group, Inc. (NASDAQ:ZG) Shares Bought by abrdn plc

abrdn plc lifted its position in Zillow Group, Inc. (NASDAQ:ZG – Free Report) by 110.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 18,328 shares of the technology company’s stock after buying an additional 9,633 shares during the quarter. abrdn plc’s holdings in Zillow […]

Canada , China , United-states , America , Amy-bohutinsky , Bradleyd-owens , Quarter-for-zillow-group , Exchange-commission , China-universal-asset-management-co , Nasdaq , Wealthfront-advisers , Invesco-ltd

DexCom (NASDAQ:DXCM) Given New $160.00 Price Target at Raymond James

DexCom (NASDAQ:DXCM) Given New $160.00 Price Target at Raymond James
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , China , Canada , Matthew-vincent-dolan , Kevinr-sayer , Raymond-james , Commonwealth-equity-services , Dexcom-inc , Slatestone-wealth , Securities-exchange-commission , Royal-bank , Dexcom-company-profile

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Short Interest Down 16.9% in April

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Free Report) saw a large decline in short interest in April. As of April 15th, there was short interest totalling 2,070,000 shares, a decline of 16.9% from the March 31st total of 2,490,000 shares. Based on an average trading volume of 2,290,000 shares, the days-to-cover ratio is presently 0.9 […]

Switzerland , China , Ohio , United-states , Swiss , Swiss-national-bank , China-universal-asset-management-co , Vanda-pharmaceuticals , Nasdaq , Vanda-pharmaceuticals-price-performance , News-ratings-for-vanda-pharmaceuticals-daily

Mizuho Lowers Sage Therapeutics (NASDAQ:SAGE) Price Target to $18.00

Mizuho Lowers Sage Therapeutics (NASDAQ:SAGE) Price Target to $18.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Texas , United-states , Switzerland , China , Swiss , Jpmorgan-chase-co , China-universal-asset-management-co , Swiss-national-bank , Needham-company , Canaccord-genuity-group , Sage-therapeutics-inc

SummerHaven Investment Management LLC Purchases 1,367 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR)

SummerHaven Investment Management LLC boosted its position in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 1.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 74,146 shares of the company’s stock after buying an additional 1,367 shares during the quarter. SummerHaven Investment Management […]

China , Citigroup , Alps-advisors-inc , Exchange-commission , Voyager-therapeutics-inc , China-universal-asset-management-co , Summerhaven-investment-management , Nasdaq , Wells-fargo-company , Kestra-advisory-services , Voyager-therapeutics